Kinins in the Pathogenesis of Cardiogenic Shock and Pain

  • F. Sicuteri
  • P. L. Del Bianco
  • M. Fanciullacci
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 9)


One usually speaks of cardiogenic shock when, as result of myocardial infarction, a severe arterial hypotension with symptoms of nervous hypoxia occurs. In some cases it actually is shock; in others the term is used incorrectly, as it is merely a failure in arterial pressure, with consequent brain hypoxia. The distinction is subtle but important both from a practical and theoretical point of view.


Myocardial Infarction Cardiogenic Shock Hemorrhagic Shock Active Biological Substance Coronary Branch 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Bassenge E., Werle E., Holtz J. and Fritz H.: “Significance of kinins in the coronary circulation”. Int. Symp. on “Cardiovascular and Neuro-Action of Bradykinin and related kinins.” Fiesole-Florence, July 1969 (in Press).Google Scholar
  2. Bavazzano A., Sidell N., Michelacci S. and Sicuteri F.: “Local ischemia as a kininogen depressant: effect of cortisone, taurine and kallikrein inhibitor”. Int. Symp. on “Cardiovascular and Neuro-Action of Bradykinin and related kinins” Fiesole-Florence, July 1969.Google Scholar
  3. Crowell J.W. and Guyton A.C.: “Evidence favoring a cardiac mechanism in irreversible hemorrhagic shock:” Am. J. Physiol. 201, 893, 1961.PubMedGoogle Scholar
  4. Edery H. and Lewis G.P.: “Inhibition of plasma kininase activity at slightly” Brit. Pharm. Chemother. 19, 299, 1962.Google Scholar
  5. Edwards W.S., Siegel A. and Bing R.J.: “Studies on myocardial metabolism. III. Coronary blood flow, myocardial oxygen consumption and carbohydrate metabolism in experimental hemorrhagic shock”. J. Clin. Invest. 33, 1646, 1954.PubMedCrossRefGoogle Scholar
  6. Erdös E.G. and Sloane E.M.: “An enzyme in human blood plasma that inactivates bradykinin and kallidins. Biochem. Pharm. II, 585, 1962.CrossRefGoogle Scholar
  7. Hackel D.B. and Goodale W.J.: “Effects of hemorrhagic shock on the heart and circulation of intact dogs”. Circulation II, 628, 1955.Google Scholar
  8. Hackel D.B. and Breitenecker R.: “Time factor in reversibility of myocardial metabolic changes in hemorrhagic shock”. Proc. Soc. Exp. Biol. and Med., 113, 534, 1963.Google Scholar
  9. Kjellmer I.: “Studies on exercise hyperemia”. Acta Physiol. Scand. 64, 244, 1965. a.Google Scholar
  10. Kjellmer I.: “The potassium Ion as a vasodilatator during the muscolar exercise”. Acta physiol. Scand. 63, 460, 1965 b.PubMedCrossRefGoogle Scholar
  11. Massion W.H., Blumel G. and Peschl L.: “The role of the plasma kinin system in cardiogenic shock and related conditions”. Proceed. Int. Symp. on “Proteasi e antiproteasi in cardiologia”, Vietri, Italy June 1969 (in press).Google Scholar
  12. Palma G. e Brusadelli S.: “Prospettive terapeutiche con inibitori enzimatici nell’infarto miocardico”. Proceed. Int. Symp. on “Proteasi e antiproteasi in cardiologia”. Vietri, Italy June 1969 (in press).Google Scholar
  13. Pitt B., Mason J., Conti C.R. and Colman R.W.: “Activation of the plasma kalli-krein system during myocardial ischemia”. Int. Symp. on “Cardiovascular and neuro-actions of Bradykinin and related kinins”. Fiesole-Florence, July 1969 (in press).Google Scholar
  14. Rocha y Silva M.: “Chemical mediators of the acute inflammatory reaction”. Ann. N.Y. Acad. Sci. 116, 899, 1964.CrossRefGoogle Scholar
  15. Sicuteri F.: “La mediazione chimica del dolore coronarico”. Mal. Cardiovasc. suppl. 2, 37, 1964.Google Scholar
  16. Sicuteri F.: “Vasoneuroactive substances and their implication in vascolar pain” on Res. Clin. Stud. Headache. S.Karger I, 6, 1967.Google Scholar
  17. Sicuteri F., Fanciullacci M., Franchi G. e Del Bianco P.L.: “Serotonin-bradykinin potentiation on receptors in man”. Life Science 4, 309, 1965.CrossRefGoogle Scholar
  18. Sicuteri F., Franchi G., Del Bianco P.L. e Del Bene E.: “A contribution to the interpretation of shock and pain in myocardial infarction” Mal. Cardiovasc. 8, 3, 1967.Google Scholar
  19. Sicuteri F., Franchi G., Fanciullacci M., Giotti A., e Guidotti A.: “Sulla azione an-tianginosa di un aminoacido solforato non coronarodilatatore”. Clin. Terapeutica 49, 205, 1959.Google Scholar
  20. Sotgiu G.: “Azione dell’inibitore delle proteasi (Trasylol) neU’infarto miocardico”. Boll. Sci. Med. 136, 279, 1964.Google Scholar
  21. Welty J.D. Jr. and Read W.O.: “Studies on some cardiac effects of taurine”. J. Pharm. Exp. Ther. 144, 110, 1964.Google Scholar

Copyright information

© Plenum Press, New York 1970

Authors and Affiliations

  • F. Sicuteri
    • 1
  • P. L. Del Bianco
    • 1
  • M. Fanciullacci
    • 1
  1. 1.Department of Medicine, Division of Clinical PharmacologyUniversity of FlorenceItaly

Personalised recommendations